BCLI Price Target | Brainstorm Cell Therapeutics Stock Forecast & Ratings

Brainstorm Cell Therapeutics (BCLI)

NASDAQ:BCLI

BCLI

Brainstorm Cell Therapeutics
$7.31
$1.57
(17.68%)
At close: Feb 26 4:00PM EST
251Followers

Brainstorm Cell Therapeutics
Price Target & Analyst Ratings

Showing:

Analyst Rating Consensus

Currently not enough data available to determine analyst consensus.

Please return soon as the page is updated accordingly.

Analyst Price Target on BCLI

Currently not enough data available to determine analyst price target.

Please return soon as the page is updated accordingly.

Detailed list of analyst forecasts

Filters

Position

Action

Ranking

Analyst Ratings
Article
Upgrade to Premium
See the 10 most recent recommendationsSee the 10 most recent ratings
Filter the opinions of outperforming analystsFilter the opinions of top analysts
Upgrade Now

*TipRanks is the most comprehensive analyst research database in the world

Upgrade to Premium
See the 10 most recent recommendationsSee the 10 most recent ratings
Filter the opinions of outperforming analystsFilter the opinions of top analysts
Upgrade Now

*TipRanks is the most comprehensive analyst research database in the world

Upgrade to Premium
See the 10 most recent recommendationsSee the 10 most recent ratings
Filter the opinions of outperforming analystsFilter the opinions of top analysts
Upgrade Now

*TipRanks is the most comprehensive analyst research database in the world

Upgrade to Premium
See the 10 most recent recommendationsSee the 10 most recent ratings
Filter the opinions of outperforming analystsFilter the opinions of top analysts
Upgrade Now

*TipRanks is the most comprehensive analyst research database in the world

See the highest rated stocks in the Consumer Goods sector

Rate Gauge
Get More with TipRanks Premium
What's Included in PREMIUM?
  • Make informed decisions based on Top Analysts' activity
  • Know what industry insiders are buying
  • Get actionable alerts from top Wall Street Analysts
  • Find out before anyone else which stock is going to shoot up
  • Get powerful stock screeners & detailed portfolio analysis

Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.